neuroendocrine tumor

You have access
⁹⁰Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study
Benedikt M. Schaarschmidt, Moritz Wildgruber, Roman Kloeckner, James Nie, Verena Steinle, Arthur J.A.T. Braat, Fabian Lohoefer, Hyun S. Kim, Harald Lahner, Manuel Weber and Jens Theysohn

Journal of Nuclear Medicine May 1, 2022, 63 (5) 679-685; DOI: https://doi.org/10.2967/jnumed.121.262561
You have access
A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of ⁶⁸Ga-NODAGA-LM3 and ⁶⁸Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors
Wenjia Zhu, Yuejuan Cheng, Ru Jia, Hong Zhao, Chunmei Bai, Jianming Xu, Shaobo Yao and Li Huo

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1398-1405; DOI: https://doi.org/10.2967/jnumed.120.253096
You have access
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
Open Access
Effects of Repeated ¹³¹I-Meta-Iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activity in Patients with Metastatic Neuroendocrine Tumors
Keiichiro Yoshinaga, Takashige Abe, Shozo Okamoto, Yuko Uchiyama, Osamu Manabe, Yoichi M. Ito, Naomi Tamura, Natsue Ito, Naho Yoshioka, Komei Washino, Nobuo Shinohara, Nagara Tamaki and Tohru Shiga

Journal of Nuclear Medicine May 10, 2021, 62 (5) 685-694; DOI: https://doi.org/10.2967/jnumed.120.250803
You have access
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
Rudolf A. Werner, Thorsten Derlin, Steven P. Rowe, Lena Bundschuh, Gabriel T. Sheikh, Martin G. Pomper, Sebastian Schulz, Takahiro Higuchi, Andreas K. Buck, Frank M. Bengel, Ralph A. Bundschuh and Constantin Lapa

Journal of Nuclear Medicine April 1, 2021, 62 (4) 514-520; DOI: https://doi.org/10.2967/jnumed.120.245464
You have access
Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of ¹⁷⁷Lu-DOTA-EB-TATE
Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Cheng, Zhaohui Zhu and Xiaoyuan Chen

Journal of Nuclear Medicine March 1, 2021, 62 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.120.248658
You have access
Head-to-Head Comparison of ⁶⁸Ga-DOTA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: A Prospective Study
Wenjia Zhu, Yuejuan Cheng, Xuezhu Wang, Shaobo Yao, Chunmei Bai, Hong Zhao, Ru Jia, Jianming Xu and Li Huo

Journal of Nuclear Medicine June 1, 2020, 61 (6) 897-903; DOI: https://doi.org/10.2967/jnumed.119.235093
You have access
The Academic NDA: Justification, Process, and Lessons Learned
John J. Sunderland

Journal of Nuclear Medicine April 1, 2020, 61 (4) 480-487; DOI: https://doi.org/10.2967/jnumed.119.238287
You have access
Improving Contrast and Detectability: Imaging with [⁵⁵Co]Co-DOTATATE in Comparison with [⁶⁴Cu]Cu-DOTATATE and [⁶⁸Ga]Ga-DOTATATE
Thomas L. Andersen, Christina Baun, Birgitte B. Olsen, Johan H. Dam and Helge Thisgaard

Journal of Nuclear Medicine February 1, 2020, 61 (2) 228-233; DOI: https://doi.org/10.2967/jnumed.119.233015
You have access
A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on ⁶⁸Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors
Anni Gålne, Helen Almquist, Martin Almquist, Cecilia Hindorf, Tomas Ohlsson, Erik Nordenström, Anna Sundlöv and Elin Trägårdh

Journal of Nuclear Medicine December 1, 2019, 60 (12) 1717-1723; DOI: https://doi.org/10.2967/jnumed.119.226332

Main menu

User menu

Search

neuroendocrine tumor

Pages